Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 332

1.

Validation of a blood protein signature for non-small cell lung cancer.

Mehan MR, Williams SA, Siegfried JM, Bigbee WL, Weissfeld JL, Wilson DO, Pass HI, Rom WN, Muley T, Meister M, Franklin W, Miller YE, Brody EN, Ostroff RM.

Clin Proteomics. 2014 Aug 1;11(1):32. doi: 10.1186/1559-0275-11-32. eCollection 2014.

PMID:
25114662
[PubMed]
Free PMC Article
2.

CREB-Induced Inflammation Is Important for Malignant Mesothelioma Growth.

Westbom CM, Shukla A, MacPherson MB, Yasewicz EC, Miller JM, Beuschel SL, Steele C, Pass HI, Vacek PM, Shukla A.

Am J Pathol. 2014 Oct;184(10):2816-27. doi: 10.1016/j.ajpath.2014.06.008. Epub 2014 Aug 8.

PMID:
25111229
[PubMed - in process]
3.

Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee.

Pass HI, Giroux D, Kennedy C, Ruffini E, Cangir AK, Rice D, Asamura H, Waller D, Edwards J, Weder W, Hoffmann H, van Meerbeeck JP, Rusch VW; IASLC Staging Committee and Participating Institutions.

J Thorac Oncol. 2014 Jun;9(6):856-64. doi: 10.1097/JTO.0000000000000181.

PMID:
24807157
[PubMed - in process]
Free PMC Article
4.

Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation.

Cioce M, Canino C, Goparaju C, Yang H, Carbone M, Pass HI.

Cell Death Dis. 2014 Apr 10;5:e1167. doi: 10.1038/cddis.2014.136.

PMID:
24722292
[PubMed - in process]
5.

Disulfiram suppresses growth of the malignant pleural mesothelioma cells in part by inducing apoptosis.

Cheriyan VT, Wang Y, Muthu M, Jamal S, Chen D, Yang H, Polin LA, Tarca AL, Pass HI, Dou QP, Sharma S, Wali A, Rishi AK.

PLoS One. 2014 Apr 1;9(4):e93711. doi: 10.1371/journal.pone.0093711. eCollection 2014.

PMID:
24690739
[PubMed - in process]
Free PMC Article
6.

Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications.

Suraokar MB, Nunez MI, Diao L, Chow CW, Kim D, Behrens C, Lin H, Lee S, Raso G, Moran C, Rice D, Mehran R, Lee JJ, Pass HI, Wang J, Momin AA, James BP, Corvalan A, Coombes K, Tsao A, Wistuba II.

Ann Oncol. 2014 Jun;25(6):1184-92. doi: 10.1093/annonc/mdu127. Epub 2014 Mar 24.

PMID:
24669013
[PubMed - in process]
7.

CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells.

Jamal S, Cheriyan VT, Muthu M, Munie S, Levi E, Ashour AE, Pass HI, Wali A, Singh M, Rishi AK.

PLoS One. 2014 Mar 5;9(3):e89146. doi: 10.1371/journal.pone.0089146. eCollection 2014.

PMID:
24598827
[PubMed - in process]
Free PMC Article
8.

Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma.

Cioce M, Ganci F, Canu V, Sacconi A, Mori F, Canino C, Korita E, Casini B, Alessandrini G, Cambria A, Carosi MA, Blandino R, Panebianco V, Facciolo F, Visca P, Volinia S, Muti P, Strano S, Croce CM, Pass HI, Blandino G.

Oncogene. 2013 Nov 18. doi: 10.1038/onc.2013.476. [Epub ahead of print]

PMID:
24240684
[PubMed - as supplied by publisher]
9.

Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling.

Qi F, Okimoto G, Jube S, Napolitano A, Pass HI, Laczko R, Demay RM, Khan G, Tiirikainen M, Rinaudo C, Croce A, Yang H, Gaudino G, Carbone M.

Am J Pathol. 2013 Nov;183(5):1654-66. doi: 10.1016/j.ajpath.2013.07.029.

PMID:
24160326
[PubMed - indexed for MEDLINE]
10.

Biomarkers and prognostic factors for mesothelioma.

Pass HI.

Ann Cardiothorac Surg. 2012 Nov;1(4):449-56. doi: 10.3978/j.issn.2225-319X.2012.10.04. No abstract available.

PMID:
23977535
[PubMed]
Free PMC Article
11.

microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer.

Cazzoli R, Buttitta F, Di Nicola M, Malatesta S, Marchetti A, Rom WN, Pass HI.

J Thorac Oncol. 2013 Sep;8(9):1156-62. doi: 10.1097/JTO.0b013e318299ac32.

PMID:
23945385
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells.

Hillegass JM, Miller JM, MacPherson MB, Westbom CM, Sayan M, Thompson JK, Macura SL, Perkins TN, Beuschel SL, Alexeeva V, Pass HI, Steele C, Mossman BT, Shukla A.

Part Fibre Toxicol. 2013 Aug 13;10:39. doi: 10.1186/1743-8977-10-39.

PMID:
23937860
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Lung cancer, histologic stratification, and resection extent: something for surgeons to think about.

Pass HI.

J Natl Cancer Inst. 2013 Aug 21;105(16):1168-9. doi: 10.1093/jnci/djt197. Epub 2013 Aug 7. No abstract available.

PMID:
23926068
[PubMed - indexed for MEDLINE]
Free Article
14.

Overexpression of EPH receptor B2 in malignant mesothelioma correlates with oncogenic behavior.

Goparaju C, Donington JS, Hsu T, Harrington R, Hirsch N, Pass HI.

J Thorac Oncol. 2013 Sep;8(9):1203-11. doi: 10.1097/JTO.0b013e31829ceb6a. Erratum in: J Thorac Oncol. 2013 Dec,8(12):1586.

PMID:
23887168
[PubMed - indexed for MEDLINE]
15.

Surgical approach to locally advanced non-small cell lung cancer.

Donington JS, Pass HI.

Cancer J. 2013 May-Jun;19(3):217-21. doi: 10.1097/PPO.0b013e318299f647. Review.

PMID:
23708068
[PubMed - indexed for MEDLINE]
16.

Mesothelioma: closer to the target?

Pass HI.

Lancet Oncol. 2013 May;14(6):448-9. doi: 10.1016/S1470-2045(13)70139-6. Epub 2013 Apr 12. No abstract available.

PMID:
23583605
[PubMed - indexed for MEDLINE]
17.

Biomarkers and molecular testing for early detection, diagnosis, and therapeutic prediction of lung cancer.

Pass HI, Beer DG, Joseph S, Massion P.

Thorac Surg Clin. 2013 May;23(2):211-24. doi: 10.1016/j.thorsurg.2013.01.002. Epub 2013 Feb 15. Review.

PMID:
23566973
[PubMed - indexed for MEDLINE]
18.

BAP1 and cancer.

Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G.

Nat Rev Cancer. 2013 Mar;13(3):153-9.

PMID:
23550303
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Extracellular signal-regulated kinase 5: a potential therapeutic target for malignant mesotheliomas.

Shukla A, Miller JM, Cason C, Sayan M, MacPherson MB, Beuschel SL, Hillegass J, Vacek PM, Pass HI, Mossman BT.

Clin Cancer Res. 2013 Apr 15;19(8):2071-83. doi: 10.1158/1078-0432.CCR-12-3202. Epub 2013 Feb 27.

PMID:
23446998
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Fibulin-3 as a biomarker for pleural mesothelioma.

Pass HI, Goparaju C.

N Engl J Med. 2013 Jan 10;368(2):190. doi: 10.1056/NEJMc1213514. No abstract available.

PMID:
23301743
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk